Low-dose venlafaxine-associated liver toxicity in chronic hepatitis
dc.authorid | 0000-0001-6203-5039 | |
dc.authorid | 0000-0002-8328-3565 | |
dc.contributor.author | Şencan, İrfan | |
dc.contributor.author | Şahin, İdris | |
dc.contributor.author | Özçetin, Adnan | |
dc.date.accessioned | 2021-06-23T19:18:04Z | |
dc.date.available | 2021-06-23T19:18:04Z | |
dc.date.issued | 2004 | |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | |
dc.description.abstract | Venlafaxine is metabolized in the liver by the isoenzyme CYP2D6. Venlafaxine-associated adverse effects have been reported, such as gastrointestinal and autonomic effects. With the usage of high dosages of venlafaxine,1 adverse effects such as toxic hepatitis have been reported,2,3 but toxic hepatitis has not been reported at low doses of venlafaxine such as 37.5 mg/day. We report a case of probable toxic hepatitis associated with a low dose of venlafaxine in a patient with a history of chronic hepatitis. | en_US |
dc.identifier.doi | 10.1345/aph.1D205 | |
dc.identifier.endpage | 353 | en_US |
dc.identifier.issn | 1060-0280 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 14742779 | en_US |
dc.identifier.scopus | 2-s2.0-1642580645 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 352 | en_US |
dc.identifier.uri | https://doi.org/10.1345/aph.1D205 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/5629 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000188188100030 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Şencan, İrfan | |
dc.institutionauthor | Şahin, İdris | |
dc.institutionauthor | Özçetin, Adnan | |
dc.language.iso | en | en_US |
dc.publisher | Harvey Whitney Books Co | en_US |
dc.relation.ispartof | Annals Of Pharmacotherapy | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chronic Hepatitis | en_US |
dc.subject | Liver Toxicity | |
dc.subject | Venlafaxine | |
dc.title | Low-dose venlafaxine-associated liver toxicity in chronic hepatitis | en_US |
dc.type | Letter | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- irfan-sencan3.pdf
- Boyut:
- 19.55 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam metin/ Full text